A study that looks into the potential of wearables to non-invasively measure blood glucose has come up with promising results ...
What's going on in Columbus and the surrounding area? Find out in our Things to Do feature which looks ahead to many area ...
The vision I had of touring the globe, of sharing music and stories, seemed suddenly at risk. Especially since I didn’t have anyone to look up to in the public spotlight to show that I could still ...
The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
Dexcom’s investigational 15-day continuous glucose monitor has a lower mean absolute relative difference than the current ...
3don MSN
In a new study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated the accuracy of the 15.5-day ...
Nanowear, a leader in home-based cardiometabolic digital diagnostics announced that SimpleSenseâ„¢, a nanotechnology-enabled wearable, mobile and software diagnostics platform, will ingest glucose data ...
CGMs are transforming health tracking for non-diabetics, providing insights into glucose levels and influencing dietary choices and athletic performance.
19h
Zacks Investment Research on MSNDXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results